LexGo

CJEU rules that free samples of OTC medicinal products can be provided to pharmacists
15/06/2020

 

On 11 June 2020, the Court of Justice of the European Union (CJEU) confirmed that it is prohibited to distribute free samples of prescription-only medicines to pharmacists but clarified – against the Advocate General's opinion of 20 January 2020 – that the prohibition does not extend to over-the-counter (OTC) products. 

Background

Before the German courts, Novartis successfully objected to the supply by Ratiopharm of free samples of a generic version of Novartis' Voltaren Schmerzgel (a pain relief gel with the active ingredient diclofenac) to pharmacists "for demonstration purposes". Ratiopharm appealed to the Bundesgerichtshof, which submitted a request for a preliminary ruling based on Article 96 of Directive (EU) No 2001/83/EC relating to medicinal products for human use (hereinafter the "Directive"). This provision permits, under strict conditions, the supply of free samples of medicinal products to persons qualified to prescribe them, i.e. physicians. In short, the Bundesgerichtshof asked the CJEU whether the supply of free samples under Article 96 of the Directive extends to pharmacists.

Distinction between prescription-only and OTC medicinal products 

Article 96(1) of the Directive sets out the conditions under which samples of medicinal products can be provided to "persons qualified to prescribe medicinal products" (limitation on the number of samples, only upon written request, subject to an adequate system of control and accountability and an obligatory summary of product characteristics). Article 96(2) authorises the Member States to adopt more restrictive measures in this regard.

The CJEU confirmed that Article 96 cannot be interpreted as authorising the supply of free samples of medicinal products to pharmacists, since they do not belong to the category of "persons qualified to prescribe medicinal products".

However, the CJEU went on to find that Article 96(1) applies to prescription-only medicinal products, which are potentially dangerous and whose use requires supervision by a physician, not to all medicinal products. Article 96(2) must be read in conjunction with Article 96(1) and has the same scope. Consequently, it relates only to medicinal products requiring a prescription.

In its interpretation, the CJEU relied on the Directive's distinction between OTC and prescription-only medicinal products, including the impact of this distinction on the possibility to advertise the products. Prescription-only medicines give rise to certain risks in relation to their use or effects and require supervision by persons qualified to prescribe them. Over-the-counter medicinal products, on the other hand, are not associated with the same risks. The CJEU mentioned Recital 51, which states that, under certain restrictive conditions, it should be possible to provide samples of medicinal products free of charge to persons qualified to prescribe (i.e. physicians) or supply (i.e. pharmacists) them, so that they can familiarize themselves with new products and acquire experience in dealing with them.

These considerations led to the conclusion that the Directive allows the supply of free samples of medicinal products to pharmacists under national law, subject to strict conditions in keeping with the Directive's purpose and provided the products concerned do not require a prescription.

Application to Belgium: Royal Decree of 11 January 1993

In Belgium, the Royal Decree of 11 January 1993 restricts the supply of free samples of medicinal products to persons qualified to prescribe them and hospital pharmacies (Article 1 in conjunction with Articles 2 and 5).

As the CJEU ruled that national law cannot prohibit the supply to pharmacists of free samples of OTC medicinal products, Belgian law will have to be amended to allow for this possibility.

Related : Nautadutilh Avocats Luxembourg Sàrl ( Mr. Vincent Wellens )

[+ http://www.nautadutilh.com]


All articles European Law

Lastest articles European Law

Optional deferral of the EU Mandatory Disclosure Directive reporting obligations
25/06/2020

On 24 June 2020, the Council of the European Union (the Council) adopted an amendment to the Mandatory Disclosure Directiv...

Read more

CJ rules Luxembourg fiscal unity regime infringes EU law (B & others)
16/06/2020

On 14 May 2020, the CJ delivered its judgment in case B and Others v Administration des contributions directes (...

CJ rules Luxembourg  fiscal unity regime infringes EU law (B & others) Read more

Mergers: European Commission opens in-depth investigation into Air Canada's proposed acquisition ...
02/06/2020

On 25 May 2020, the European Commission decided to open an in-depth investigation under the EU Merger Regulation into the ...

Mergers: European Commission opens in-depth investigation into Air Canada's proposed acquisition of Transat Air Read more

The modification of a vertical tax consolidation group into a horizontal tax consolidation group ...
19/05/2020

On 14 May 2020, the Court of Justice of the European Union (“CJEU”) ruled on the Luxembourg tax consolidation ...

Read more

Lastest articles by Mr. Vincent Wellens

Data protection impact assessments: new EDPS recommendations
06/07/2020

On 6 July 2020, the European Data Protection Supervisor (EDPS) published a report on the use of data protection impact ass...

Read more

CJEU renders important decision on the liability of online platforms in trade mark infringement c...
07/04/2020

On 2 April 2020, the Court of Justice of the European Union (“CJEU”) rendered a judgment (C-567/18) clarifying...

Read more

EU Copyright: lending out vehicles with radio receivers is not a “communication to the public”
03/04/2020

On 2 April 2020, the Court of Justice of the European Union (“CJEU”) rendered a judgment (C-753/18) ...

Read more

Contracts and commercial litigation: Covid-19 as an unforeseeable event and/or a material adverse...
27/03/2020

For contracts governed by Luxembourg law, the parties may wish to consider if the COVID-19 outbreak has rendered the oblig...

Read more

LexGO Network